title: Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
authors.affiliation: From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (P.J.N., J.T.C.), and the Department of Health Policy and Management, Harvard School of Public Health (M.C.W.) - both in Boston.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Neumann
authors.forename: Joshua T
authors.initials: JT
authors.lastname: Cohen
authors.forename: Milton C
authors.initials: MC
authors.lastname: Weinstein
mesh_terms: D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006291:Health Policy / Q000191:economics*; D006801:Humans; D018803:Models, Economic; D019057:Quality-Adjusted Life Years; D014481:United States